Praxis Precision Medicines Inc (PRAX)

01:33 AM

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap DownHere's Why - MarketBeat

01:33 AM

08:49 AM

PRAX Secures FDA Alignment on Relutrigine Program - GuruFocus

08:49 AM

08:00 AM

Praxis (NASDAQ: PRAX) Q4 2025 interim may back 2026 relutrigine NDA in SCN2A & SCN8A - Stock Titan

08:00 AM

07:14 AM

Is Praxis Precision Medicines Inc. stock a contrarian buyMarket Performance Report & Daily Stock Momentum Reports - newser.com

07:14 AM

04:14 AM

Published on: 2025-11-04 03:14:53 - newser.com

04:14 AM

Nov 03, 2025

Oppenheimer Lifts Price Target for Praxis Medicines (PRAX), Keeps Outperform Rating - MSN

Nov 03, 2025

Nov 03, 2025

Is a relief rally coming for Praxis Precision Medicines Inc. holdersQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com

Nov 03, 2025

Nov 03, 2025

How analysts rate Praxis Precision Medicines Inc. stock today2025 Fundamental Recap & Low Risk Growth Stock Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

What institutional flow reveals about Praxis Precision Medicines Inc.2025 Fundamental Recap & Weekly High Momentum Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Is Praxis Precision Medicines Inc. stock near bottom after decline2025 Buyback Activity & AI Enhanced Trading Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

What valuation multiples suggest for Praxis Precision Medicines Inc. stockJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com

Nov 03, 2025

Nov 03, 2025

How institutional buying supports Praxis Precision Medicines Inc. stockJuly 2025 Sector Moves & Verified Short-Term Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Published on: 2025-11-03 06:18:43 - newser.com

Nov 03, 2025

Nov 03, 2025

Can Praxis Precision Medicines Inc. stock deliver surprise earnings beatWeekly Risk Summary & High Yield Equity Trading Tips - newser.com

Nov 03, 2025

Nov 03, 2025

Applying big data sentiment scoring on Praxis Precision Medicines Inc.Bull Run & Reliable Volume Spike Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Using Python tools to backtest Praxis Precision Medicines Inc. strategiesWeekly Volume Report & Weekly High Conviction Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Published on: 2025-11-03 03:06:20 - newser.com

Nov 03, 2025

Nov 03, 2025

Does Praxis Precision Medicines Inc. qualify in momentum factor screeningJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com

Nov 03, 2025

Nov 02, 2025

Published on: 2025-11-02 22:52:57 - newser.com

Nov 02, 2025

Nov 02, 2025

How Praxis Precision Medicines Inc. stock valuations compare to rivalsTrade Analysis Summary & Long-Term Capital Growth Strategies - newser.com

Nov 02, 2025

Nov 01, 2025

Praxis Precision Medicines prices $525M public offering - MSN

Nov 01, 2025

Nov 01, 2025

Published on: 2025-11-01 00:59:14 - newser.com

Nov 01, 2025

Oct 31, 2025

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 1-Year HighHere's What Happened - MarketBeat

Oct 31, 2025

Oct 31, 2025

Praxis Precision Medicines stock hits 52-week high at $206.36 By Investing.com - Investing.com Australia

Oct 31, 2025

Oct 31, 2025

Published on: 2025-10-31 03:19:21 - newser.com

Oct 31, 2025

Oct 31, 2025

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Oct 31, 2025

Oct 30, 2025

Praxis Precision Medicines stock hits 52-week high at $206.36 - Investing.com

Oct 30, 2025

Oct 30, 2025

Praxis Precision Medicines (PRAX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Oct 30, 2025

Oct 30, 2025

Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: Should You Buy? - sharewise.com

Oct 30, 2025

Oct 29, 2025

Published on: 2025-10-29 21:58:45 - newser.com

Oct 29, 2025

Oct 29, 2025

What’s Happening With Praxis Stock? - Trefis

Oct 29, 2025

Oct 29, 2025

Does Positive Phase 3 Data for Ulixacaltamide Transform the Outlook for Praxis Precision Medicines (PRAX)? - Sahm

Oct 29, 2025

Oct 29, 2025

Published on: 2025-10-29 03:41:05 - newser.com

Oct 29, 2025

Oct 29, 2025

Praxis Precision Medicines’ PRAX-562 Trial: A Potential Game-Changer for Epileptic Encephalopathies - TipRanks

Oct 29, 2025